Medpace Holdings, Inc. · Commercial Physical & Biological Research

MEDP

Low riskNext report: Around Feb 8, 2027 (est.)

View price ↗

The short version

A high-quality, profitable business with growing sales.

Going well

Profitable every year for 10 years
Sales up 20% last year
Brings in more cash than it spends

Money moves

Insiders sold $31.9M in the last 30 days
Institutions added 2.9% to their holdings in the quarter ending June 2026 (272 bought, 401 sold)
Held by Ray Dalio (Bridgewater), Terry Smith (Fundsmith)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$676.85+1.1% that day

Company value: $18.9B; Share price times all shares
Price vs profit (P/E): 37.6x; You pay about $38 for each $1 of yearly profit
Price vs sales: 7.5x; Company value is 7.5 times a year of sales
Cash vs value: 4%; Cash as a share of company value

From MEDP's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Profit, Sep '26

$137.5M+24% vs a year earlier

Dec '23Tap a barSep '26

Last 12 months: $517.8M, up 20% from the 12 months before.

What the price assumes

Your guesses, our math

Move the sliders to your own view of MEDP. Starting points are the company's recent numbers.

Sales growth+22% a yearRecently: +22% a yearProfit margin20%Last 12 months: 20.5%P/E at the end38xToday: 37.6x. Many steady companies trade at 12x to 25xShare count change-4% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$6.8B

Profit in 5 years$1.4B

Price these guesses point to$2,278.76+237% vs $676.85 todayAbout +27% a year, before dividends

What today's price needs: with a 20% margin and a 38x P/E, sales could shrink about 4.3% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

5/5Strong

PassReturn on equity 15%+Earns a lot on the money owners have in the business.70.2%
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.17.8%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$681.9M
PassShare count not growingNot diluting owners. Falling means buybacks.-12.3% in 3 years

Revenue: $2.5B; +20.0% vs prior year
5-year growth: +22.3%/yr; revenue, per year
Current ratio: 0.74x; short-term assets / bills due
Free cash flow: $681.9M; 26.9% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: debt under half of equity, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Sep 30, 2026

Reported Oct 21After close4:15 pm ET

EPS: $4.84; vs $3.86
Free cash flow: $196.4M
Share count: -1.5%; vs a year ago

Insider rating

Last 90 days

23Selling

1 insider sold $59.3M (not pre-planned)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

56/ 100

This week: 4
Normal week: 3.1
vs normal: 1.3x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+2.9%

Institutions added 2.9% to their holdings. 272 bought, 401 sold. 2 quarters of net buying in a row.

Shares held by institutions24.7M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-3.0%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

Total liabilities $1.7B

Shares outstandingLatest reported

28M

Earnings reports

Last 12

Next reportAround Feb 8, 2027 (est.)Estimated from the same quarter last year

Results filedOct 21
Results filedJul 22
Results filedApr 22
Results filedFeb 9
Results filedOct 22, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (active)Sep 28 · View filing ↗Activist New 5%+ holder (passive)Aug 14 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$59.3M1 insider, 0 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
August J. TroendlePresident & CEO	Sell	49K	$623.03	$30.3M	338K	Sep 30Filing ↗
-12.6% of their holdings $621.02 to $625.47 across 2 trades Traded Sep 29 to Sep 30 Not a pre-planned sale Also Director and 10% owner Filed 1 day after
August J. TroendlePresident & CEO	Sell	3K	$620.10	$1.6M	387K	Sep 28Filing ↗
-0.7% of their holdings $620.07 to $620.60 across 2 trades Traded Sep 25 to Sep 28 Not a pre-planned sale Also Director and 10% owner Filed 1 day after
August J. TroendlePresident & CEO	Sell	44K	$624.01	$27.4M	389K	Sep 24Filing ↗
-10.1% of their holdings $621.33 to $628.64 across 2 trades Traded Sep 23 to Sep 24 Not a pre-planned sale Also Director and 10% owner Filed 1 day after